Atara Biotherapeutics, Inc. (ATRA)
6.69
+0.19
(+2.92%)
USD |
NASDAQ |
Nov 18, 16:00
6.69
0.00 (0.00%)
After-Hours: 20:00
Atara Biotherapeutics Debt to Equity Ratio : -1.325 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | -1.325 |
| June 30, 2026 | -1.390 |
| March 31, 2026 | -1.382 |
| December 31, 2025 | -1.371 |
| September 30, 2025 | -1.600 |
| June 30, 2025 | -1.668 |
| March 31, 2025 | -1.462 |
| December 31, 2024 | -0.864 |
| September 30, 2024 | -0.9728 |
| June 30, 2024 | -0.8103 |
| March 31, 2024 | -0.9393 |
| December 31, 2023 | -0.5832 |
| September 30, 2023 | -1.216 |
| June 30, 2023 | 8.681 |
| March 31, 2023 | 1.040 |
| December 31, 2022 | 0.5662 |
| September 30, 2022 | 0.351 |
| June 30, 2022 | 0.2486 |
| March 31, 2022 | 0.0778 |
| December 31, 2021 | 0.1012 |
| September 30, 2021 | 0.0792 |
| June 30, 2021 | 0.0367 |
| March 31, 2021 | 0.0315 |
| December 31, 2020 | 0.0328 |
| September 30, 2020 | 0.0371 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.0352 |
| March 31, 2020 | 0.0546 |
| December 31, 2019 | 0.0549 |
| September 30, 2019 | 0.0505 |
| June 30, 2019 | 0.0705 |
| March 31, 2019 | 0.0554 |
| December 31, 2018 | 0.0022 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.0098 |
| December 31, 2017 | 0.0028 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0518 |
| Alnylam Pharmaceuticals, Inc. | 0.8316 |
| Anika Therapeutics, Inc. | 0.1901 |
| Savara, Inc. | 0.2815 |
| Arrowhead Pharmaceuticals, Inc. | 27.84 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 18.61M |
| Total Liabilities (Quarterly) | 56.51M |
| Shareholders Equity (Quarterly) | -37.90M |
| Current Ratio | 1.722 |
| Net Debt Paydown Yield | 1.90% |